Streetbeat News

Price Targets

NDAQ

Rosenblatt analyst Andrew Bond has reiterated a 'Buy' rating on Nasdaq (NASDAQ:NDAQ) and maintained a price target of $82.

Portfolio Pulse from richadhand@benzinga.com

July 20, 2023 | 11:10 am

CALX

Rosenblatt analyst Mike Genovese has reinstated Calix (NYSE:CALX) with a Buy rating and maintains a $70 price target.

Portfolio Pulse from richadhand@benzinga.com

July 20, 2023 | 11:08 am

CCEP

Barclays analyst Lauren Lieberman has maintained an Overweight rating on Coca-Cola Europacific (NASDAQ:CCEP) but lowered the price target from $75 to $72.

Portfolio Pulse from Benzinga Newsdesk

July 20, 2023 | 11:08 am

NFLX

Rosenblatt analyst Barton Crockett maintains a Neutral rating on Netflix (NASDAQ:NFLX) and raises the price target from $358 to $400.

Portfolio Pulse from richadhand@benzinga.com

July 20, 2023 | 11:07 am

NFLX

B of A Securities analyst Jessica Ehrlich maintains a Buy rating on Netflix and raises the price target from $490 to $525.

Portfolio Pulse from Benzinga Newsdesk

July 20, 2023 | 11:07 am

STGW

Needham analyst Laura Martin has reiterated a 'Buy' rating on Stagwell (NASDAQ:STGW) and maintained a $10 price target.

Portfolio Pulse from richadhand@benzinga.com

July 20, 2023 | 11:05 am

CLX

Barclays analyst Lauren Lieberman maintains an Underweight rating on Clorox (NYSE:CLX) and has lowered the price target from $124 to $117.

Portfolio Pulse from Benzinga Newsdesk

July 20, 2023 | 11:04 am

CHD

Barclays analyst Lauren Lieberman maintains an Underweight rating on Church & Dwight Co (NYSE:CHD) and lowers the price target from $83 to $78.

Portfolio Pulse from Benzinga Newsdesk

July 20, 2023 | 11:03 am

BF

Barclays analyst Lauren Lieberman maintains an Equal-Weight rating on Brown Forman Inc Class B Common Stock (NYSE:BF) and raises the price target from $67 to $70.

Portfolio Pulse from Benzinga Newsdesk

July 20, 2023 | 11:01 am

APLS

Wells Fargo analyst Derek Archila has maintained an Equal-Weight rating on Apellis Pharmaceuticals (NASDAQ:APLS) but lowered the price target from $76 to $53.

Portfolio Pulse from Benzinga Newsdesk

July 20, 2023 | 10:58 am